SAP NetWeaver® Fund Makes Strategic Investment in ArisGlobal

Delivering on its commitment to help customers and partners experience the business value of enterprise service-oriented architecture (enterprise SOA), SAP AG (NYSE: SAP) today announced it has made a minority investment in ArisGlobal Holdings LLC (ArisGlobal), a leading provider of pharmacovigilance and safety, registration information management, clinical trials management and medical communications software solutions to the pharmaceutical, biotechnology, medical device and clinical research organization (CRO) markets. Today’s announcement marks the second investment for SAP’s $125 million global SAP NetWeaver® Fund and underscores SAP’s commitment to fuel the development of innovative solutions built on the SAP NetWeaver® platform. The announcement was made at the EMEA Enterprise Services Partner Summit, being held today in Amsterdam.

“As part of the SAP ecosystem, ArisGlobal is committed to delivering innovative solutions that take advantage of the SAP NetWeaver platform,” said Deepak Abbhi, CEO of ArisGlobal. “Together, SAP and ArisGlobal have made a commitment to co-innovate and will develop and execute a joint road map that is based on the SAP NetWeaver platform and that brings unparalleled value to our combined customer base. This investment will enable us to accelerate our growth and development on the SAP NetWeaver platform.”

ArisGlobal software helps companies meet international regulatory requirements, manage risk, improve operational efficiencies and easily share mission-critical information on a global basis. The company received “Powered by SAP NetWeaver®” status for ArisGlobal Register™, its comprehensive registration and regulatory submission tracking software that enables customers to track all registration and on-going submissions, as well as maintain critical product data, such as formulations, indications, packaging, release specifications, manufacturing procedures and other detailed product information required for global regulatory and QA compliance. As ArisGlobal Register is now a “Powered by SAP NetWeaver” solution, customers can rapidly deploy Register within environments using the SAP NetWeaver platform and access Register functionality within SAP NetWeaver® Portal. ArisGlobal has offices in the United States, U.K. Germany, India and Japan; Its software solutions are used by more than 100 life science companies including major pharmaceutical companies around the world.

“Like SAP, ArisGlobal has a significant presence in the life sciences industry and a strong portfolio of products, including its flagship solutions in pharmacovigilance and safety,” said Emiel van Schaik, head of Industry Solution Management for Consumer Products and Life Sciences, SAP. “We believe that ArisGlobal’s Register product, now ‘Powered by SAP NetWeaver’ certified, is positioned to take the lead in this emerging market. We look forward to continuing to co-innovate with ArisGlobal for the benefit of our mutual customers.”

Read the complete Press Release